Chester County News and Community Website
WILMINGTON, DE — Reviv announced it has surpassed 20,000 customers worldwide, marking a major milestone in its mission to make advanced, affordable at-home treatments for TMJ disorder, teeth grinding, and …
Reviv Surpasses 20,000 Global Customers With Breakthrough TMJ and Wellness Devices Read More
WILMINGTON, DE — Edify Engine, a Delaware-based technology company, announced the Solana integration of its AI-powered platform that lets users design and deploy immersive 3D worlds directly on-chain. The move …
Edify Engine Expands to Solana, Bringing AI-Driven 3D World Building On-Chain Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) reported financial results for the fourth quarter and full fiscal year ended September 30, 2025, while providing guidance for fiscal 2026. The global …
Ashland Reports Fourth-Quarter and Fiscal 2025 Results, Issues 2026 Outlook Read More WILMINGTON, DE — Edify Engine, a Delaware-based technology company, has officially launched its public platform, giving users the ability to create and publish immersive, interactive 3D worlds through simple AI …
Delaware Startup Edify Engine Launches ‘WordPress of 3D’ for the Web3 Era Read More
WILMINGTON, DE — Vasco Electronics has introduced the Vasco Translator Q1, a next-generation language device capable of translating real-time conversations in 113 languages — and now, for the first time, …
Vasco Electronics Unveils AI-Powered Translator That Mimics Your Voice Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced a series of strategic updates aimed at sharpening its development priorities and extending its financial runway. The biotechnology company has executed …
Prelude Therapeutics Reshapes Pipeline With Incyte Deal and Strategic Refocus Read More WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has entered into an exclusive option agreement with Incyte Corporation (Nasdaq: INCY) for its mutant-selective JAK2V617F JH2 inhibitor program, a next-generation therapy …
Prelude Strikes $910 Million Deal With Incyte for Groundbreaking JAK2 Cancer Therapy Read More WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the publication of two abstracts featuring preclinical data from its JAK2V617F mutant-selective inhibitor program and CALR-targeted degrader antibody conjugates (DACs) discovery …
Prelude Therapeutics Highlights Groundbreaking Blood Cancer Research at ASH 2025 Read More
WILMINGTON, DE — The Bancorp, Inc. (NASDAQ: TBBK) reported another solid quarter of growth, driven by strong fintech lending activity, higher transaction volumes, and an aggressive share repurchase strategy.
The Bancorp Posts Strong Q3, Boosted by Fintech Expansion and Share Buybacks Read More
WILMINGTON, DE — The WSFS CARES Foundation, the charitable arm of WSFS Financial Corporation (Nasdaq: WSFS), announced a $50,000 grant to Social Finance, Inc. to support the launch of the …
WSFS CARES Foundation Awards $50,000 Grant to Expand Family Housing Initiative Read More